SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-002427
Filing Date
2020-02-03
Accepted
2020-02-03 17:14:44
Documents
4
Group Members
ABC BETEILIGUNGEN AKTIENGESELLSCHAFTALTECH ADVANCED MATERIALS AGDELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTDEUTSCHE BALATON BIOTECH AGHANSJORG PLAGGEMARSHEIDELBERGER BETEILIGUNGSHOLDING AGMARNA BETEILIGUNGEN AGMING LE SPORTS AGPRISMA EQUITY AGRALPH BIE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 TO SCHEDULE 13D sc13d0120a9abc_biofrontera.htm SC 13D/A 383827
2 JOINT FILING AGREEMENT sc13d0120a9abcex99-2_bio.htm EX-99.2 25433
3 ACTING IN CONCERT AGREEMENT, DATED JANUARY 28, 2019, BY AND AMONG ABC BETEILIGUN sc13d0120a9abcex99-3_bio.htm EX-99.3 111055
4 POWER OF ATTORNEY sc13d0120a9abcex99-4_bio.htm EX-99.4 4766
  Complete submission text file 0001213900-20-002427.txt   527107
Mailing Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0
Business Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0 49 6221 64727-0
DEUTSCHE BALATON AKTIENGESELLSCHAFT (Filed by) CIK: 0001571071 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Subject) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90509 | Film No.: 20569605
SIC: 2834 Pharmaceutical Preparations